Vabomere Is a New Combo Antibiotic for Rare Drug-Resistant Infections

December 2017

Vabomere (meropenem/vaborbactam, VAY-boh-meer) will be the first "carbapenem/beta-lactamase inhibitor" antibiotic combo.

Vaborbactam helps meropenem outsmart bacteria that are otherwise resistant to carbapenems.

But don't expect Vabomere to fly off your shelves. There are only about 9,000 carbapenem-resistant infections each year in the U.S.

Practical advice for a better career, with unlimited access to CE

Hospital Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Shortages Use Strategies to Avoid Mix-Ups Due to Injectable Med Shortages
Antibiotics Vabomere Is a New Combo Antibiotic for Rare Drug-Resistant Infections
Transplantation Keep Oral Cyclosporine Products Straight
Vaccines Be Aware of the Differences Between Shingrix and Zostavax
Cancer Expedite Orders for Meds to Treat Tumor Lysis Syndrome
Insulin Think of Fiasp as Faster-Acting NovoLog
Medication Errors Remember "One Shake, Two Shake" With Reconstituted Oral Meds
Appropriate Med Use Be Aware of Med Indications That Are "Off the Beaten Path"
Constipation Symproic Will Join Movantik and Relistor for Opioid-Induced Constipation
Sickle Cell Disease Endari Will Be a New Specialty Med for Sickle Cell Disease